APA (7th ed.) Citation

Bashir Lawal, Bashir Lawal, Yu-Chi Wang, Alexander T. H. Wu, Alexander T. H. Wu, Alexander T. H. Wu, . . . Hsu-Shan Huang. (2021). Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Bashir Lawal, et al. Pro-Oncogenic C-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment Are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Bashir Lawal, et al. Pro-Oncogenic C-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment Are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives. Frontiers Media S.A., 2021.